The estrogen receptor alpha (ERα) -Src-p190 RhoGAP signaling axis plays a pivotal role in modulating breast cancer cell behavior within the bone microenvironment and has been increasingly recognized as a critical driver of skeletal metastasis, particularly in ER-positive subtypes. Here, ESR1 is linked to breast cancer.